Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan

NCT06852079 is registered in ClinicalTrials.gov with Abdul Bari as lead sponsor.

NCT NCT06852079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06852079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan
Lead sponsor
Abdul Bari
Phase
Phase 3
Overall status
Recruiting
Start date
December 23, 2023
Completion date
December 31, 2025
Enrollment
119 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension